IOPtima's Acquisition

IOPtima was acquired by Chengdu Kanghong Pharmaceutical Group on November 21, 2017.

IOPtima is a developer of minimally-invasive surgical ophthalmic devices. The company's flagship product, the IOPtimate, is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser …

Articles about IOPtima's Acquisition: